Molecular Diagnostics Market & Forecast (By Application, Technology, Countries, Companies & Clinical Trials) to 2017: Global Analysis

Publisher Name :
Date: 08-Apr-2013
No. of pages: 158
Inquire Before Buying

Global Molecular Diagnostics Market & Future Forecast to 2017 Overview

The global molecular diagnostics market is witnessing a period of profound growth. The growth is coming from different regions and markets. The next five years will witness significant developments in molecular diagnostics such as automation, as well as introduction of a wide range of new products. Molecular Diagnostics involves multiple technologies to identify genetic variations in individual patients. These technologies include PCR, FISH, hybrid capture, sequencing and microarrays. The increase in the aging population and incidences of various chronic diseases are driving the demand of molecular diagnostics world over. The industry is getting a push from every side and many factors collectively are fuelling the growth in this industry. Growing with a CAGR of 14.64 percent global molecular diagnostics market is expected to double its market size in 2017 from the market of 2012.

Molecular Diagnostics Market – Application Segment Analysis

•    The infectious disease testing is the leading application in Molecular Diagnostic. It is likely to hold XXXX% share in 2017.
•    Molecular oncology tests have emerged as a second significant rapidly growing market segment. Genetic Testing and Blood Screening are at the third and fourth spot respectively in 2012.
•    The cardiovascular disease testing and neurological testing are closely competing with each other to gain the maximum market share.
•    Food testing market is expected to inch up to US$ XXXX Million in 2017.
Technologies Segment Analysis
•    Biochips and PCR based test accounts for the largest shares in the molecular diagnostics technologies segment with XXXX% and XXXX% respectively in 2012.
•    Fish & Innovations technology market is at the 3rd slot.
•    The PCR related technologies and Non- PCR market is at the 4th and 5th position respectively.
•    The biosensor and Molecular Imaging technology are also showing impressive growth.
Geographical Analysis
•    United States molecular diagnostic market is expected to be more than double by 2017 from its current market in 2012.
•    Europe stands at the second position in the global molecular diagnostic market.
•    China, Japan and India are expected to stand at 3rd, 4th and 5th slot respectively.
•    The Mexico molecular diagnostics market is predicted to grow at a CAGR of 17% between 2012 and 2017.
Company Wise Analysis
•    The Roche molecular diagnostic share is greater than the combined share of Myriad Genetics and Qiagen which holds the 2nd and 3rd position respectively.
•    Abbott stands at the 4th spot and expected to generate sales worth US$ XXXX Million by the year 2017.
•    The Myriad Genetics molecular diagnostic sales were worth US$ XXXX Million in 2012.

Renub Research study titled “Molecular Diagnostics Market & Forecast (By Application, Technology, Countries, Companies & Clinical Trials) to 2017: Global Analysis” provides a comprehensive assessment of the fast-evolving, high-growth Global Molecular Diagnostics market. This 158 page report with 81 Figures and 23 Tables studies the Global Molecular Diagnostics: 1) Market and Forecast 2) Application Wise Market & Forecast 3) Geographical Market & Forecast 4) Technology Wise Market & Forecast 5) Company Wise molecular Diagnostics sales & Forecast 6) Molecular Diagnostic & Personalized Medicines 7) Clinical trials In Molecular Diagnostics Landscape.

The Report Covers the Following Points
•    Global Molecular Diagnostic Market (2010-12) and Forecast (2013 to 2017)
•    Global Molecular Diagnostic Application Segment (Infectious Disease Testing, Virology Testing, HAI Testing, HPV Testing, Critical Care Infectious Testing, Blood Screening, Genetic Testing, Oncology Testing, Tissue Typing, Cardiovascular Disease Testing, Neurological Disorders Testing, Food Pathogen Detection Testing & Others) Market (2010-2012) and Forecast (2013 to 2017)
•    Molecular Diagnostic Technology Segment (PCR Based Test, PCR Related Technologies , Non-PCR Test, Fish & Innovations Testing, Biochips/Microarrays, Biosensors, Molecular Imaging, & Other Technologies) Market (2010-2012) and Forecast (2013 to 2017)
•    Molecular Diagnostic Geographical Distribution (US, Europe, China, Japan, India, Brazil, Mexico, South Korea and Rest of World) Market (2010-2012) and Forecast (2013 to 2017)
•    Molecular Diagnostic Sales Company Wise Analysis (Roche, Abbott, Myriad Genetics, Qiagen, BioMérieux and Others ) Market (2010-2012) and Forecast (2013 to 2017)
•    Molecular Diagnostic and Road to Personalized medicine
•    Molecular Diagnostic Clinical Trial Statements (20 Clinical Trials Studied in the report)
•    Driving Forces & Challenges for Global Molecular Diagnostic Market

Data Sources

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Renub Research team of industry experts.

Primary sources include industry surveys and telephone interviews with industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 100 paid databases.

Molecular Diagnostics Market & Forecast (By Application, Technology, Countries, Companies & Clinical Trials) to 2017: Global Analysis

Table of Contents

1. Executive Summary

2. Molecular Diagnostics Market & Forecast - (2010 - 2017)

3. Molecular Diagnostics Market Share - (2010 - 2017)
3.1 Share & Forecast - Application Wise
3.2 Share & Forecast - Technology Wise
3.3 Share & Forecast - Region Wise
3.4 Share & Forecast - Company Wise

4. Molecular Diagnostics Market (Application Segment) - (2010 - 2017)
4.1 Infectious Disease Testing Market & Forecast
4.1.1 Virology (HIV, HCV, HBV) Testing Market & Forecast
4.1.2 Health - Associated Infections (HAI) Testing Market & Forecast
4.1.3 HPV Testing Market & Forecast
4.1.4 Critical Care Infectious Testing Market & Forecast
4.2 Blood Screening Market & Forecast
4.3 Genetic Testing Market & Forecast
4.4 Oncology Testing Market & Forecast
4.5 Tissue Typing (HLA Testing) Market & Forecast
4.6 Cardiovascular Disease Testing Market & Forecast
4.7 Neurological Disorders Testing Market & Forecast
4.8 Food Pathogen Detection Testing Market & Forecast
4.9 Miscellaneous Testing Market & Forecast

5. Molecular Diagnostics Market (Technologies Segment) - (2010 - 2017)
5.1 PCR Based Test Market & Forecast
5.2 PCR Related Technologies Market & Forecast
5.3 Non-PCR Test Market & Forecast
5.4 Fish & Innovations Testing Market (Fluorescent in-situ hybridization) & Forecast
5.5 Biochips/Microarrays Market & Forecast
5.6 Biosensors Market & Forecast
5.7 Molecular Imaging Market & Forecast
5.8 Other Technologies Market & Forecast

6. Geographical Distribution - Molecular Diagnostics Market - (2008 - 2017)
6.1 United States Molecular Diagnostics Market & Forecast
6.2 Europe Molecular Diagnostics Market & Forecast
6.3 China Molecular Diagnostics Market & Forecast
6.4 Japan Molecular Diagnostics Market & Forecast
6.5 India Molecular Diagnostics Market & Forecast
6.6 Brazil Molecular Diagnostics Market & Forecast
6.7 Mexico Molecular Diagnostics Market & Forecast
6.8 South Korea Molecular Diagnostics Market & Forecast
6.9 Rest of World Molecular Diagnostics Market & Forecast

7. Molecular Diagnostics Market (Company Wise) - (2010 - 2017)
7.1 Roche Molecular Diagnostics Market & Forecast
7.2 Abbott Molecular Diagnostics Market & Forecast
7.3 Myriad Genetics Molecular Diagnostics Market & Forecast
7.4 Qiagen Molecular Diagnostics Market & Forecast
7.5 BioMérieux Molecular Diagnostics Market & Forecast
7.6 Other Companies Molecular Diagnostics Market & Forecast

8. Molecular Diagnostics and Personalized Medicine
8.1 Road to Personalized Medicine
8.1.1 Historical perspective: HIV & Oncology
8.1.2 Other Applications: Met & Unmet Therapy Areas
8.2 Molecular Diagnostics Technologies
8.2.1 Expression Profiling - RNA & Pharmacogenomics
8.2.2 Expression Profiling - Proteins & Pharmacoproteomics
8.2.3 DNA Sequence Profiling - Pharmacogenetic & SNP Analysis
8.2.4 DNA Sequence Profiling - High-Throughput Sequencing
8.3 Molecular Diagnostics and Personalized Medicine: Value-Assessed Opportunities for Multiple Stakeholders Values, Needs & Expectations
8.4 Regulatory Authorities
8.5 Molecular Diagnostics as Companion Diagnostics: Value-Driven Adoption
8.5.1 Behavioral Impact
8.5.2 Economic Impact (Value-Based vs. Cost-Plus Pricing)

9. Molecular Diagnostics Clinical Trial Statement
9.1 Detecting Respiratory Viruses in Upper and Lower Respiratory Tract Samples
9.2 Crizotinib Efficacy In Non-Small Cell Lung Cancer Patients With Anaplastic Lymphoma Kinase (ALK) Translocation
9.3 A Clinical Trial to Assess the Efficacy and Safety of the Conversion to Everolimus
9.4 Accuracy Testing of the Chromosomal Aberration and Gene Mutation Markers of the AMLProfiler
9.5 A Two Arm, Multi-Centre Clinical Evaluation of the xTAG Respiratory Viral Panel v3 Test
9.6 Collecting and Storing Tissue Samples from Patients with Rare or Cutaneous Non-Hodgkin Lymphoma
9.7 Biopsies of Cancer Patients for Tumor Molecular Characterization
9.8 Daptomycin versus Vancomycin in the Treatment of Nosocomial or Healthcare-associated MRSA Bacteremia
9.9 Collection of Tissue Samples for Cancer Research
9.10 Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
9.11 Total Therapy Study XVI for Newly Diagnosed Patients with Acute Lymphoblastic Leukemia
9.12 Tumor Genomic Profiling in Patients Evaluated for Targeted Cancer Therapy
9.13 Congenital Muscle Disease Study of Patient and Family Reported Medical Information
9.14 Molecular and Diagnostic Classification of Non-Small Cell Lung Cancer from Fine Needle Aspirates
9.15 Extending Molecular Responses with Nilotinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) Patients in Chronic Phase
9.16 CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib
9.17 Relating Clinical Outcomes in Multiple Myeloma to Personal Assessment of Genetic Profile
9.18 Safety and Efficacy of Nilotinib in Newly Diagnosed Chronic Myeloid Leukemia Patients
9.19 Radotinib versus Imatinib in Newly Diagnosed Philadelphia Chromosome and Chronic Myeloid Leukemia Chronic Phase Patients
9.20 Molecularly Determined Treatment of Diffuse Intrinsic Pontine Gliomas (DIPG)

10. Molecular Diagnostics Market - Drivers
10.1 Various Developments in the Molecular Diagnostics Landscape
10.2 Increasing Investment in Genomics & Proteomics Research
10.3 Technological Advances in Molecular Diagnostics
10.4 Increasing Acceptance of the Personalized Medicine
10.5 Growing Molecular Diagnostics for Food Safety

11. Molecular Diagnostics Market - Challenges
11.1 Regulatory Issues
11.2 Various Factors Slowing Growth of Molecular Diagnostics
11.3 Reimbursement Capabilities
11.4 Quality Checkpoints, Awareness & Acceptance

List of Tables
Table 3 1: Global Molecular Diagnostics - Company Wise Market Share (Percent), 2010 - 2012
Table 3 2: Global Molecular Diagnostics - Forecast for Company Wise Market Share (Percent), 2013 - 2017
Table 8 1: Molecular Platforms for Companion Diagnostics
Table 9 1: Detecting Respiratory Viruses in Upper and Lower Respiratory Tract Samples - Clinical Trials, 2012
Table 9 2: Crizotinib Efficacy in Non-Small Cell Lung Cancer Patients with Anaplastic Lymphoma Kinase Translocation - Clinical Trials, 2012
Table 9 3: A Clinical Trial to Assess the Efficacy and Safety of the Conversion to Everolimus - Clinical Trials, 2012
Table 9 4: Accuracy Testing of the Chromosomal Aberration and Gene Mutation Markers of the AMLProfiler - Clinical Trials, 2012
Table 9 5: A Two Arm, Multi-Centre Clinical Evaluation of the xTAG Respiratory Viral Panel v3 Test - Clinical Trials, 2013
Table 9 6: Collecting and Storing Tissue Samples from Patients with Rare or Cutaneous Non-Hodgkin Lymphoma - Clinical Trials, 2012
Table 9 7: Biopsies of Cancer Patients for Tumor Molecular Characterization - Clinical Trails, 2012
Table 9 8: Daptomycin versus Vancomycin in the Treatment of Nosocomial or Healthcare-associated MRSA Bacteremia - Clinical Trials, 2013
Table 9 9: Collection of Tissue Samples for Cancer Research - Clinical Trials, 2012
Table 9 10: Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma - Clinical Trials, 2012
Table 9 11: Total Therapy Study XVI for Newly Diagnosed Patients with Acute Lymphoblastic Leukemia - Clinical Trials, 2012
Table 9 12: Tumor Genomic Profiling in Patients Evaluated for Targeted Cancer Therapy, 2013
Table 9 13: Congenital Muscle Disease Study of Patient and Family Reported Medical Information - Clinical Trials, 2013
Table 9 14: Molecular and Diagnostic Classification of Non-Small Cell Lung Cancer from Fine Needle Aspirates - Clinical Trials, 2013
Table 9 15: Extending Molecular Responses with Nilotinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) Patients in Chronic Phase - Clinical Trials, 2012
Table 9 16: CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib - Clinical Trial, 2013
Table 9 17: Relating Clinical Outcomes in Multiple Myeloma to Personal Assessment of Genetic Profile - Clinical Trials, 2013
Table 9 18: Safety and Efficacy of Nilotinib in Newly Diagnosed Chronic Myeloid Leukemia Patients - Clinical Trials, 2012
Table 9 19: Radotinib versus Imatinib in Newly Diagnosed Philadelphia Chromosome and Chronic Myeloid Leukemia Chronic Phase Patients - Clinical Trials, 2012
Table 9 20: Molecularly Determined Treatment of Diffuse Intrinsic Pontine Gliomas (DIPG) - Clinical Trials, 2012

List of Figures
Figure 2 1: Global - Molecular Diagnostics Market (Million US$), 2010 - 2012
Figure 2 2: Global - Forecast for Molecular Diagnostics Industry (Million US$), 2013 - 2017
Figure 3 1: Global Molecular Diagnostics - Application Wise Market Share (Percent), 2010 - 2012
Figure 3 2: Global Molecular Diagnostics - Forecast for Application Wise Market Share (Percent), 2013 - 2017
Figure 3 3: Global Molecular Diagnostics - Technology Wise Market Share (Percent), 2010 - 2012
Figure 3 4: Global Molecular Diagnostics - Forecast for Technology Wise Market Share (Percent), 2013 - 2017
Figure 3 5: Global Molecular Diagnostics - Region Wise Market Share (Percent), 2010 - 2012
Figure 3 6: Global Molecular Diagnostics - Forecast for Region Wise Market Share (Percent), 2013 - 2017
Figure 4 1: Global - Infectious Disease Testing Market (Million US$), 2010 - 2012
Figure 4 2: Global - Forecast for Infectious Disease Testing Market (Million US$), 2013 - 2017
Figure 4 3: Global - Virology Testing Market (Million US$), 2010 - 2012
Figure 4 4: Global - Forecast for Virology Testing Market (Million US$), 2013 - 2017
Figure 4 5: Global - HAI Testing Market (Million US$), 2010 - 2012
Figure 4 6: Global - Forecast for HAI Testing Market (Million US$), 2013 - 2017
Figure 4 7: Global - HPV Testing Market (Million US$), 2010 - 2012
Figure 4 8: Global - Forecast for HPV Testing Market (Million US$), 2013 - 2017
Figure 4 9: Global - Critical Care Infectious Testing Market (Million US$), 2008 - 2012
Figure 4 10: Global - Forecast for Critical Care Infectious Testing Market (Million US$), 2013 - 2017
Figure 4 11: Global - Blood Screening Market (Million US$), 2007 - 2012
Figure 4 12: Global - Forecast for Blood Screening Market (Million US$), 2013 - 2017
Figure 4 13: Global - Genetic Testing Market (Million US$), 2010 - 2012
Figure 4 14: Global - Forecast for Genetic Testing Market (Million US$), 2013 - 2017
Figure 4 15: Global - Oncology Market (Million US$), 2010 - 2012
Figure 4 16: Global - Forecast for Oncology Market (Million US$), 2013 - 2017
Figure 4 17: Global - Tissue Typing Market (Million US$), 2008 - 2012
Figure 4 18: Global - Forecast for Tissue Typing Market (Million US$), 2013 - 2017
Figure 4 19: Global - Cardiovascular Disease Testing Market (Million US$), 2010 - 2012
Figure 4 20: Global - Forecast for Cardiovascular Disease Testing Market (Million US$), 2013 - 2017
Figure 4 21: Global - Neurological Disorders Testing Market (Million US$), 2010 - 2012
Figure 4 22: Global - Forecast for Neurological Disorders Testing Market (Million US$), 2013 - 2017
Figure 4 23: Global - Food Pathogen Detection Testing Market (Million US$), 2010 - 2012
Figure 4 24: Global - Forecast for Food Pathogen Detection Testing Market (Million US$), 2013 - 2017
Figure 4 25: Global - Miscellaneous Testing Market (Million US$), 2010 - 2012
Figure 4 26: Global - Forecast for Miscellaneous Testing Market (Million US$), 2013 - 2017
Figure 5 1: Global - PCR Based Test Market (Million US$), 2010 - 2012
Figure 5 2: Global - Forecast for PCR Based Test Market (Million US$), 2013 - 2017
Figure 5 3: Global - PCR Related Technologies Market (Million US$), 2010 - 2012
Figure 5 4: Global - Forecast for PCR Related Technologies Market (Million US$), 2013 - 2017
Figure 5 5: Global - Non-PCR Test Market (Million US$), 2010 - 2012
Figure 5 6: Global - Forecast for Non-PCR Test Market (Million US$), 2013 - 2017
Figure 5 7: Global - Fish & Innovations Market (Million US$), 2010 - 2012
Figure 5 8: Global - Forecast for Fish & Innovations Market (Million US$), 2013 - 2017
Figure 5 9: Global - Biochips/ Microarrays Market (Million US$), 2010 - 2012
Figure 5 10: Global - Forecast for Biochips/Micrroarrays Market (Million US$), 2013 - 2017
Figure 5 11: Global - Biosensors Market (Million US$), 2010 - 2012
Figure 5 12: Global - Forecast for Biosensors Market (Million US$), 2013 - 2017
Figure 5 13: Global - Molecular Imaging Market (Million US$), 2010 - 2012
Figure 5 14: Global - Forecast for Molecular Imaging Market (Million US$), 2013 - 2017
Figure 5 15: Global - Other Technologies Market (Million US$), 2010 - 2012
Figure 5 16: Global - Forecast for Other Technologies Market (Million US$), 2012 - 2017
Figure 6 1: US - Molecular Diagnostics Market (Million US$), 2002 - 2012
Figure 6 2: US - Forecast for Molecular Diagnostics Market (Million US$), 2013 - 2017
Figure 6 3: Europe - Molecular Diagnostics Market (Million US$), 2010 - 2012
Figure 6 4: Europe - Forecast for Molecular Diagnostics Market (Million US$), 2013 - 2017
Figure 6 5: China - Molecular Diagnostics Market (Million US$), 2010 - 2012
Figure 6 6: China - Forecast for Molecular Diagnostics Market (Million US$), 2013 - 2017
Figure 6 7: Japan - Molecular Diagnostics Market (Million US$), 2010 - 2012
Figure 6 8: Japan - Forecast for Molecular Diagnostics  Industry (Million US$), 2013 - 2017
Figure 6 9: India - Molecular Diagnostics Market (Million US$), 2010 - 2012
Figure 6 10: India - Forecast for Molecular Diagnostics  Industry (Million US$), 2013 - 2017
Figure 6 11: Brazil - Molecular Diagnostics Market (Million US$), 2007 - 2012
Figure 6 12: Brazil - Forecast for Molecular Diagnostics  Industry (Million US$), 2013 - 2017
Figure 6 13: Mexico - Molecular Diagnostics Market (Million US$), 2007 - 2012
Figure 6 14: Mexico - Forecast for Molecular Diagnostics  Industry (Million US$), 2013 - 2017
Figure 6 15: South Korea - Molecular Diagnostics Market (Million US$), 2005 - 2012
Figure 6 16: South Korea - Forecast for Molecular Diagnostics  Industry (Million US$), 2013 - 2017
Figure 6 17: Rest of World - Molecular Diagnostics Market (Million US$), 2010 - 2012
Figure 6 18: Rest of World - Forecast for Molecular Diagnostics  Industry (Million US$), 2013 - 2017
Figure 7 1: Roche - Molecular Diagnostics Sales (Million US$), 2008 - 2012
Figure 7 2: Roche - Forecast for Molecular Diagnostics Sales (Million US$), 2013 - 2017
Figure 7 3: Abbott - Molecular Diagnostics Sales (Million US$), 2010 - 2012
Figure 7 4: Abbott - Forecast for Molecular Diagnostics Sales (Million US$), 2013 - 2017
Figure 7 5: Myriad Genetics - Molecular Diagnostics Sales (Million US$), 2007 - 2012
Figure 7 6: Myriad Genetics - Forecast for Molecular Diagnostics Sales (Million US$), 2013 - 2017
Figure 7 7: Qiagen - Molecular Diagnostics Sales (Million US$), 2009 - 2012
Figure 7 8: Qiagen - Forecast for Molecular Diagnostics Sales (Million US$), 2013 - 2017
Figure 7 9: BioMérieux - Molecular Diagnostics Sales (Million US$), 2010 - 2012
Figure 7 10: BioMérieux - Forecast for Molecular Diagnostics Sales (Million US$), 2013 - 2017
Figure 7 11: Other Companies - Molecular Diagnostics Sales (Million US$), 2010 - 2012
Figure 7 12: Other Companies - Forecast for Molecular Diagnostics Sales (Million US$), 2013 - 2017
Figure 8 1: A Healthcare ?Value-Net

 

  • Healthy Diet Demand In Developed Economies To Boost Nutraceuticals
    As customers scuffle to keep up with the frantic lifestyles, the necessity for healthy nutrition rises owing to dearth of time to spend on laborious exercises.  Customers are shifting their attention to swift and healthy food behaviours. Increase in intake of beverages and functional food has offered makers of nutraceuticals with money-spinning prospects to benefit [...]
  • World Economic Forum Unveils Top 10 Emerging Technologies of 2016
    The World Economic Forum (WEF) and Scientific American lately unveiled the major technological innovation list of the top ten emerging technologies of 2016. This list emphasizes on the technological developments which have the supremacy to transform industries, protect the planet, and improve lives. It also presents an opening to discuss any societal, human, economic or [...]
  • Siemens Adds To the Growth of Wind Power Generation Market
    Siemens has been presenting ground-breaking strategies and pioneering solutions for energy generation for an intelligent power supply globally. With an expansive portfolio and wide-ranging proficiency in wind power generation, Siemens is likely to aid in increasing the share of wind power in the US energy mix. With New Mexico’s vicinity to significant wind energy areas, [...]
  • Global Public Safety LTE Ecosystem Overview
    In view of its flourishing ecosystem, spectrum flexibility and performance metrics, LTE has emerged as the leading candidate for public safety mobile broadband networks. Public safety organizations and establishments have already begun planning to advance their networks to LTE-based public safety solutions. LTE provisions a varied range of services, from high bandwidth data services to [...]
  • RnR Market Research: Biochips Market Insights
    Growing R&D investment and subcontracting of pharmaceutical companies would lead to growth in biochips market in Asia along with an increase in the application of biochips products is estimated to improve opportunity for the global biochip market. Conversely, the high cost involved in manufacturing of biochips can be seen as a challenge for the same. [...]
  • 2016 Molecular Blood Typing, Grouping and Infectious Disease NAT Market: Instrument and Reagent Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Strategies--France, Germany, Italy, Japan, Spain, UK, US
    Published: 09-Sep-2016        Price: US 35500 Onwards        Pages: 775
    Complete report $35,500.  DataPack (test volumes, sales forecasts, supplier shares) $19,500.This comprehensive seven-country report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global molecular blood banking market during the next five years, and assist industry executives in developing effective business, new product development and marketing strategies.  The report e......
  • 2016 Europe Molecular Blood Typing, Grouping and Infectious Disease NAT Market: Instrument and Reagent Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Strategies--France, Germany, Italy, Spain, UK
    Published: 09-Sep-2016        Price: US 19700 Onwards        Pages: 600
    Complete report $19,700.  DataPack (test volumes, sales forecasts, supplier shares) $12,800.This comprehensive five-country report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the European blood banking market during the next five years, and assist industry executives in developing effective business, new product development and marketing strategies. The report expl......
  • 2016 France Molecular Blood Typing, Grouping and Infectious Disease NAT Market: Instrument and Reagent Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Strategies
    Published: 09-Sep-2016        Price: US 6100 Onwards        Pages: 430
    Complete report $6,100.  DataPack (test volumes, sales forecasts, supplier shares) $3,950.VPGMarketResearch.com's new strategic analysis is prepared in order to help current suppliers and potential market entrants identify and evaluate emerging opportunities and assist industry executives in developing effective business, new product development and marketing strategies.RationaleDuring the next five years, ......
  • 2016 UK Molecular Blood Typing, Grouping and Infectious Disease NAT Market: Instrument and Reagent Supplier Shares, Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Strategies
    Published: 09-Sep-2016        Price: US 6100 Onwards        Pages: 422
    Complete report $6,100.  DataPack (test volumes, sales forecasts, supplier shares) $3,950. VPGMarketResearch.com's new strategic analysis is prepared in order to help current suppliers and potential market entrants identify and evaluate emerging opportunities and assist industry executives in developing effective business, new product development and marketing strategies.    RationaleDuring the ......
  • 2016 US Molecular Blood Typing, Grouping and Infectious Disease NAT Market: Instrument and Reagent Supplier Shares, Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Strategies
    Published: 09-Sep-2016        Price: US 9700 Onwards        Pages: 460
    Complete report $9,700.  DataPack (test volumes, sales forecasts, supplier shares) $6,300. VPGMarketResearch.com's new strategic analysis is prepared in order to help current suppliers and potential market entrants identify and evaluate emerging opportunities and assist industry executives in developing effective business, new product development and marketing strategies.    RationaleDuring the next&nb......
  • 2016 Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Assays, and Strategic Profiles of Leading Suppliers
    Published: 09-Sep-2016        Price: US 3850 Onwards        Pages: 280
    This 280-page report presents a comprehensive analysis of the clinical significance and market needs for major blood typing, grouping, and infectious disease screening assays, including NAT tests, as well as extensive listings of companies developing or marketing new blood banking technologies and products.The report also presents strategic assessments of current and emerging suppliers, including their sales, product portfolios, marketing tactics, technological know-how, new products i......
  • 2016 Molecular Blood Banking and NAT Screening Instrumentation and Strategic Profiles of Leading Suppliers
    Published: 09-Sep-2016        Price: US 3850 Onwards        Pages: 111
    This 111-page report reviews current instrumentation technologies, and compares features of leading blood banking automated and semi-automated analyzers.The report also presents strategic assessments of current and emerging suppliers of blood banking products, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.Contains 111 pages......
  • 2016 Molecular Blood Banking and NAT Screening Technologies and Strategic Profiles of Leading Suppliers
    Published: 09-Sep-2016        Price: US 3850 Onwards        Pages: 154
    This 154-page report provides assessments of such technologies as molecular diagnostics, monoclonal and polyclonal antibodies, immunoassays, microtitration plates, IT, lasers, synthetic red cell substitutes, genetically engineered blood components, blood preservation, autologous blood transfusion/freezing and their potential applications for blood banking.                        ......
  • 2016 Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Assays, and Companies Developing New Technologies and Products
    Published: 09-Sep-2016        Price: US 3850 Onwards        Pages: 197
    The report presents a comprehensive analysis of the clinical significance and market needs for major blood typing, grouping, and infectious disease screening assays, including NAT tests, as well as extensive listings of companies developing or marketing new blood banking technologies and products.Contains 197 pages and 6 tables......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs